Sirio and Best Formulations announce US gummy manufacturing capabilities at SupplySide West

Published: 10-Oct-2023
Ingredients

Located at stand 5036, Sirio will be presenting three pieces of news with two new product announcements at SupplySide West 2023

Ahead of Supply Side West 2023, Sirio has three pieces of news with two new product announcement and in bigger news a first gummy manufacturing line in USA. The latter is expected to be ready for production at the end of October 2023. 

The new gummy production line will open at Best Formulations, its US based manufacturing facility. Once open this will provide the global CDMO with local manufacturing in three continents. The gummy development includes a dedicated R&D lab, automated lines, packaging and will specialise in the delivery of custom formulations.

In Europe, the nutraceutical CDMO has launched five seasonal products including three bioactive gummies for ‘cough and cold’, ‘oral care’ and ‘Urinary Tract Infections’ (UTI) and two softgels for menopause and eye health targeting customers who look to innovate in the consumer health space. The new formulations are designed to meet the rising demand of consumers for products with more natural actives to help OTC customers tap consumer trends.

A state-of-the-art Automated Starch-free Gummy Line at Best Formulations – purchased from Tanis OTC – is able to produce a variety of gummies including gelatin-based, pectin-based, and gelatin-pectin combinations, with both plant-base and sugar free options available.

“We are thrilled to introduce our advanced gummy manufacturing capabilities,” said Edward Shneyvas, VP of R&D, Innovation and Business Development at Best Formulations. “With our expertise in delivering tailored solutions, we remain committed to driving innovation and delighting our customers.”

  • Companies:
  • Sirio Pharma
  • Best Formulations
See more

You may also like

Ingredients

Nutraceuticals, personal care and pharma to converge as health and wellness science accelerates

Read more
A few years ago, we authored a predictive CPHI trend analysis that explored how large pharmaceutical brands were increasingly looking to attract consumers in the nutraceutical space. This year, perhaps the first truly post-COVID period, what we see is an acceleration of global wellness and people taking a more considered and longer-term approach to their overall health

Trending Articles

  1. Activating autophagy: a nutritional strategy with longevity applications As consumers prioritise their healthspan as opposed to their lifespan, the targeted use of dietary spermidine to stimulate autophagy is emerging as a promising healthy ageing approach
  2. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  4. GOED releases two market research reports: annual global omega-3 ingredient market and consumer search trends The Global Organization for EPA and DHA Omega-3s (GOED) has published two important reports detailing trends in the global EPA and DHA omega-3 industry
  5. BioCell Collagen ingestion reduces signs of UVB-induced photoageing New peer-reviewed, published research finds branded dietary matrix of hydrolysed collagen type II, chondroitin sulfate and hyaluronic acid reduced the formation of wrinkles and helped maintain skin elasticity in a laboratory study in 14 weeks

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

Nutraceuticals, personal care and pharma to converge as health and wellness science accelerates

A few years ago, we authored a predictive CPHI trend analysis that explored how large pharmaceutical brands were increasingly looking to attract consumers in the nutraceutical space. This year, perhaps the first truly post-COVID period, what we see is an acceleration of global wellness and people taking a more considered and longer-term approach to their overall health
Ingredients

From e-sports to protein gummies: driving sports nutrition growth in 2023

Ahead of Vitafoods Europe 2023, Dr Kevin Robinson spoke with Sara Lesina, General Manager, Sirio Europe, to discuss growth prospects in European sports nutrition.
Ingredients

Sirio Pharma launches immunity gummies

New products target ‘sleep and stress’ and ‘immunity’ with superior taste and texture profiles
Ingredients

SIRIO launches Plantegrity softgel range at Vitafoods

Plant-based softgel shell based on gellan gum is a more sustainable ingredient produced by natural fermentation, states the company
Ingredients

Botanicals in multiple-benefit softgels: a key trend for the next few years

Vitafoods Europe (10–12 May) returns as much of the world emerges from the coronavirus pandemic. The many changes that COVID-19 caused may, however, represent potentially significant shifts and longer-term approaches to consumer behaviour. Perhaps key among these is people’s increased awareness of their well-being and health
Ingredients

Is ginseng the root of vitality?

Rhoda El Khoury, Scientific Marketing Manager at SIRIO Europe, explores the growing body of evidence that supports ginseng health and well-being claims
Ingredients

Eyes on the prize: visual health supplements are on the rise

One of the biggest and perhaps most unexpected tends that arose during the pandemic, and one that was certainly accelerated by COVID-induced behaviours, was the rise in prominence of eye health formulations. To get an understanding of what is now emerging from these developments, and where the best growth and opportunities are, Dr Kevin Robinson spoke to Dominique Baum, MD of SIRIO Europe
Subscribe now